Pain management with stimulation subthreshold to paresthesia
Devices, systems and methods are provided for treating pain while minimizing or eliminating possible complications and undesired side effects, particularly the sensation of paresthesia. This is achieved by stimulating in proximity to a dorsal root ganglion with stimulation energy in a manner that will affect pain sensations without generating substantial sensations of paresthesia. In some embodiments, such neurostimulation takes advantage of anatomical features and functions particular to the dorsal root ganglion.
1. A method of treating pain in a patient comprising:
positioning a lead having at least one electrode disposed thereon so that at least one of the at least one electrode is in proximity to a dorsal root ganglion; and
providing stimulation energy to the at least one of the at least one electrode so as to stimulate at least a portion of the dorsal root ganglion,
wherein together the positioning of the lead step and the providing stimulation energy step reduce pain sensations without generating sensations of paresthesia.
2. A method as in claim 1 , wherein providing stimulation energy comprises providing stimulation energy at a level below a threshold for Aβ fiber recruitment.
3. A method as in claim 2 , wherein providing stimulation energy comprises providing stimulation energy at a level below a threshold for Aβ fiber cell body recruitment.
4. A method as in claim 3 , wherein providing stimulation energy comprises providing stimulation energy at a level above a threshold for M fiber cell body modulation.
5. A method as in claim 3 , wherein providing stimulation energy comprises providing stimulation energy at a level above a threshold for C fiber cell body modulation.
6. A method as in claim 3 , wherein providing stimulation energy comprises providing stimulation energy at a level above a threshold for small myelenated fiber cell body modulation.
7. A method as in claim 3 , wherein providing stimulation energy comprises providing stimulation energy at a level above a threshold for unmyelenated fiber cell body modulation.
8. A method as in claim 1 , wherein providing stimulation energy comprises providing stimulation energy at a level which is capable of modulating glial cell function within the dorsal root ganglion.
9. A method as in claim 8 , wherein providing stimulation energy comprises providing stimulation energy at a level which is capable of modulating satellite cell function within the dorsal root ganglion.
10. A method as in claim 8 , wherein providing stimulation energy comprises providing stimulation energy at a level which is capable of modulating Schwann cell function within the dorsal root ganglion.
11. A method as in claim 1 , wherein providing stimulation energy comprises providing stimulation energy at a level which is capable of causing at least one blood vessel associated with the dorsal root ganglion to release an agent or send a cell signal which affects a neuron or glial cell within the dorsal root ganglion.
12. A method as in claim 1 , wherein positioning the lead comprises advancing the lead through an epidural space so that at least a portion of the lead extends along a nerve root sleeve angulation.
13. A method as in claim 12 , wherein advancing the lead through the epidural space comprises advancing the lead in an antegrade direction.
14. A method of treating a patient comprising:
selectively electrically stimulating a small fiber cell body within a dorsal root ganglion of the patient while excluding an Aβ fiber cell body within the dorsal root ganglion of the patient.
15. A method as in claim 14 , wherein the small fiber body comprises a M fiber cell body.
16. A method as in claim 14 , wherein the small fiber body comprises a C fiber cell body.
17. A method of treating a patient comprising:
identifying a dorsal root ganglion associated with a sensation of pain by the patient; and
electrically neuromodulating at least one glial cell within the dorsal root ganglion so as to reduce the sensation of pain by the patient.
18. A method as in claim 17 , wherein the at least one glial cell comprises a satellite cell.
19. A method as in claim 17 , wherein the at least one glial cell comprises a Schwann cell.
20. A method as in claim 17 , wherein neuromodulating comprises providing stimulation at a level that reduces the sensation of pain without generating substantial sensations of paresthesia.
21. A method of treating a patient comprising:
positioning a lead having at least one electrode disposed thereon so that at least one of the at least one electrode is in proximity to a dorsal root ganglion; and
providing stimulation energy to the at least one electrode so as to stimulate at least one blood vessel associated with the dorsal root ganglion in a manner that causes the at least one blood vessel to release an agent which neuromodulates a neuron within the dorsal root ganglion.
22. A method as in claim 21 , wherein the agent comprises a neuromodulatory chemical that affects the function of neurons involved in pain sensory transduction.